.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
McKesson
UBS
US Department of Justice
Fuji
Healthtrust
Accenture
Deloitte
Medtronic
Cerilliant

Generated: June 23, 2017

DrugPatentWatch Database Preview

CHLOR-TRIMETON Drug Profile

« Back to Dashboard

What is the patent landscape for Chlor-trimeton, and when can generic versions of Chlor-trimeton launch?

Chlor-trimeton is a drug marketed by Schering, Schering Plough, and Bayer Healthcare Llc. and is included in five NDAs.

The generic ingredient in CHLOR-TRIMETON is chlorpheniramine maleate; pseudoephedrine sulfate. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine sulfate profile page.

Summary for Tradename: CHLOR-TRIMETON

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list17
Clinical Trials: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHLOR-TRIMETON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
CHLOR-TRIMETON
chlorpheniramine maleate
SYRUP;ORAL006921-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Healthcare Llc
CHLOR-TRIMETON
chlorpheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL018397-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Bayer Healthcare Llc
CHLOR-TRIMETON
chlorpheniramine maleate
TABLET, EXTENDED RELEASE;ORAL007638-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering
CHLOR-TRIMETON
chlorpheniramine maleate
TABLET;ORAL006921-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Schering Plough
CHLOR-TRIMETON
chlorpheniramine maleate
INJECTABLE;INJECTION008826-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Merck
Teva
US Department of Justice
Deloitte
Citi
Harvard Business School
Federal Trade Commission
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot